Maria Oliva Grassi, Pasquale Viggiano, Enrico Borrelli, Giacomo Boscia, Teresa Molfetta, Maria Giovanna Malerba, Maria D'Addario, Ermete Giancipoli, Giovanni Alessio, Francesco Boscia
INTRODUCTION: Optimizing treatment protocols for wet age-related macular degeneration (wAMD) is an ongoing challenge, as it involves a delicate balance between achieving therapeutic efficacy and minimizing invasive procedures' frequency. This study aimed to apply the Lean methodology and evaluate the effectiveness of this new setting on intravitreal therapy for wAMD, employing different anti-vascular endothelial growth factors (VEGF) drugs (bevacizumab, brolucizumab, aflibercept, ranibizumab), drawing data from the Bari Intravitreal Injections Registry (BIVIR)...
April 15, 2024: Ophthalmology and Therapy